Dr. Muhammad-Ali Akram Zaydan, MD
- Medicare services, 2024
- 1,068
- Medicare patients, 2024
- 88
- Part D claims, 2024
- 864
- Clinical trials
- 3
- Hospital affiliations
- 3
- Practice address
- 8211 Scicor Drive, Indianapolis, IN 46214
- Practice phone
- Call (317) 271-1200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Labcorp Central Laboratory Services
Clinical Lab - Full Service · Indianapolis, Indiana
Find Dr. Zaydan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Muhammad-Ali Akram Zaydan is a hematologist and oncologist in Indianapolis, Indiana
Dr. Zaydan practices at Labcorp Central Laboratory Services in Indianapolis, Indiana.
Dr. Zaydan's NPI, 1750350633, was assigned on March 14, 2006. Dr. Zaydan holds Kentucky license 37117.
- NPI
- 1750350633NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8224026612
- NPI enumeration date
- March 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (317) 271-1200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Muhammad-Ali Akram Zaydan practices at Labcorp Central Laboratory Services in Indianapolis, Indiana
Dr. Zaydan's primary practice is Labcorp Central Laboratory Services, at 8211 Scicor Drive, Indianapolis, IN 46214. The practice phone is (317) 271-1200.
- Labcorp Central Laboratory Services8211 Scicor Drive, Indianapolis, IN 46214Phone(317) 271-1200
Source: Dmand AI Affiliation Data
Dr. Muhammad-Ali Akram Zaydan is affiliated with 5 sites of care
Dr. Zaydan's primary practice is Labcorp Central Laboratory Services in Indianapolis, Indiana. Dr. Zaydan is also affiliated with UK St. Claire Regional Medical Center. Dmand AI also links Dr. Zaydan to 2 more hospitals and 1 physician office, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Muhammad-Ali Akram Zaydan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaydan practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Labcorp Central Laboratory Services | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Muhammad-Ali Akram Zaydan is one of 224 hematologists and oncologists in Indiana
Hematology and oncology is Dr. Zaydan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zaydan is licensed in Kentucky.
Specialties and state licenses
- Hematology and oncology, KentuckyPrimary
Hematologists and oncologists near Dr. Zaydan
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Muhammad-Ali Akram Zaydan billed Medicare for 1,068 services in 2024
CMS data shows 1,068 Medicare services from Dr. Zaydan across 8 procedure codes in 2024, for 88 Medicare patients. Medicare paid $62,820 for them. Every service was in an office.
Dr. Zaydan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7582024: 53629%
- Surgery
- 2023: 4982024: 33034%
- Tests and treatments
- 2023: 7432024: 17277%
- Imaging
- 2023: 372024: 1949%
- Other services
- 2023: 232024: 1152%
- Drugs given in the office
- 2023: 2002024: 0100%
Dr. Zaydan compared with the Indiana median for hematologists and oncologists, 2024
- Dr. Zaydan
- Indiana median
- Medicare services
- 1,068vs 76041% above
- Medicare patients
- 88vs 26467% below
- Part D claims
- 572vs 42335% above
Medians across 215 hematologists and oncologists in Indiana with Dmand AI profiles that report each measure.
Dr. Zaydan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Zaydan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Zaydan and other hematologists and oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Muhammad-Ali Akram Zaydan treated 88 Medicare patients in 2024, average age 74
CMS counts 88 Medicare patients who saw Dr. Zaydan in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Zaydan's median patient age at 67, with 52% women.
Dr. Zaydan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Zaydan's Medicare patients by sex, 2024
- Women4551%
- Men4349%
Chronic conditions among Dr. Zaydan's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Chronic kidney disease55%
- Arthritis43%
- Diabetes43%
- Cancer41%
- COPD39%
- Ischemic heart disease39%
Share of Medicare patients with each condition. A patient can have several.
Dr. Zaydan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women52%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Muhammad-Ali Akram Zaydan wrote 864 Medicare Part D claims in 2024
In 2024, Dr. Zaydan wrote 864 Medicare Part D claims for 125 patients. 86% of them were for generic drugs. CMS names the drug for 572 of them, across 26 drugs with 11 or more claims each, at $553,674 in total drug cost. In 2023, CMS named 556 claims across 24 drugs.
Dr. Zaydan's Part D claims by kind of drug, 2024
- Generic747 claims86%
- Brand-name117 claims14%
Dr. Zaydan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Zaydan's Part D claims, 2024
- Opioids10%87 of 864 claims
- Antibiotics5%43 of 864 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5562024: 5723%
Drugs named by CMS: 26 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Muhammad-Ali Akram Zaydan takes part in Medicare
Dr. Zaydan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Muhammad-Ali Akram Zaydan has worked on 3 clinical trials
Dmand AI links Dr. Zaydan to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Small Cell Lung Carcinoma, Carcinoma, Bronchogenic and Leukemia, Lymphocytic, Chronic, B-Cell.
Clinical trials with Dr. Zaydan by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Zaydan's trials
- Small Cell Lung Carcinoma
- Carcinoma, Bronchogenic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
Investigators on the most trials with Dr. Zaydan
Recent clinical trials with Dr. Zaydan
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL (opens in a new tab)
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (opens in a new tab)
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Muhammad-Ali Akram Zaydan received $26,544 in industry payments from 2016 to 2025
CMS Open Payments shows 312 general payments to Dr. Zaydan from 54 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 34% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,614.
General payments to Dr. Zaydan by program year, 2016 to 2025
General payments to Dr. Zaydan by kind, 2016 to 2025
- Consulting fees$8,88334%
- Speaker and faculty fees$5,85822%
- Food and beverage$5,60221%
- Travel and lodging$5,25920%
- Other$8183%
Companies that paid Dr. Zaydan the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Muhammad-Ali Akram Zaydan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Muhammad-Ali Akram Zaydan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Muhammad-Ali Akram Zaydan's NPI number?
Dr. Muhammad-Ali Akram Zaydan's NPI number is 1750350633. It was assigned on March 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Muhammad-Ali Akram Zaydan?
Dr. Muhammad-Ali Akram Zaydan is a hematologist and oncologist in Indianapolis, Indiana. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Muhammad-Ali Akram Zaydan practice?
Dr. Zaydan practices at 8211 Scicor Drive, Indianapolis, IN 46214. Dr. Zaydan's primary practice is Labcorp Central Laboratory Services in Indianapolis, Indiana. Dmand AI also links Dr. Zaydan to 2 hospitals and 1 physician office.
What is Dr. Muhammad-Ali Akram Zaydan's office phone number?
The practice phone on file for Dr. Zaydan is (317) 271-1200.
What is Dr. Muhammad-Ali Akram Zaydan's medical license number?
Dr. Zaydan holds Kentucky license 37117.
Which hospitals is Dr. Muhammad-Ali Akram Zaydan affiliated with?
Dr. Zaydan is affiliated with UK St. Claire Regional Medical Center. Dmand AI links Dr. Zaydan to 2 more hospitals.
Does Dr. Muhammad-Ali Akram Zaydan accept Medicare?
Yes. CMS data shows Dr. Zaydan billed Medicare for 1,068 services in 2024, and Dr. Zaydan accepts Medicare assignment.
How many Medicare patients does Dr. Muhammad-Ali Akram Zaydan see?
CMS counts 88 Medicare patients who saw Dr. Zaydan in 2024, with an average age of 74.
What services does Dr. Muhammad-Ali Akram Zaydan bill to Medicare?
In 2024, Dr. Zaydan's most billed Medicare services were office visit, established patient (99213), surgery: heart and blood vessels (36415) and infusion or chemotherapy administration (96372).
What drugs does Dr. Muhammad-Ali Akram Zaydan prescribe most?
In 2024 Medicare Part D data, Dr. Zaydan's most prescribed drugs by claims were Levothyroxine Sodium, Allopurinol and Metoclopramide HCl.
Show 3 more questionsShow fewer questions
Has Dr. Muhammad-Ali Akram Zaydan received payments from drug or device companies?
CMS Open Payments shows $26,544 in general payments to Dr. Zaydan from 54 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Muhammad-Ali Akram Zaydan been practicing?
Dr. Zaydan graduated from medical school in 1991, 35 years ago.
Does Dr. Muhammad-Ali Akram Zaydan do research?
Dr. Zaydan has worked on 3 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card